Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith Lindor

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Liver International : Official Journal of the International Association for the Study of the Liver|December 24, 2021
Machine learning in primary biliary cholangitis: A novel approach for risk stratificationAlessio Gerussi, Damiano Verda, Davide Paolo Bernasconi, et al.
Hepatology (Baltimore, Md.)|March 20, 2024
Primary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here?David E J Jones, Ulrich Beuers, Alan Bonder, et al.
Hepatology (Baltimore, Md.)|December 10, 2017
Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitisZobair M Younossi, Rohit Loomba, Mary E Rinella, et al.
Hepatology (Baltimore, Md.)|December 10, 2017
Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosisZobair M Younossi, Rohit Loomba, Quentin M Anstee, et al.
JHEP Reports : Innovation in Hepatology|October 9, 2024
Loss of biochemical response at any time worsens outcomes in UDCA-treated patients with primary biliary cholangitisSurain B Roberts, Woo Jin Choi, Lawrence Worobetz, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Liver International : Official Journal of the International Association for the Study of the Liver|December 24, 2021
Machine learning in primary biliary cholangitis: A novel approach for risk stratificationAlessio Gerussi, Damiano Verda, Davide Paolo Bernasconi, et al.
Hepatology (Baltimore, Md.)|March 20, 2024
Primary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here?David E J Jones, Ulrich Beuers, Alan Bonder, et al.
Hepatology (Baltimore, Md.)|December 10, 2017
Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitisZobair M Younossi, Rohit Loomba, Mary E Rinella, et al.
Hepatology (Baltimore, Md.)|December 10, 2017
Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosisZobair M Younossi, Rohit Loomba, Quentin M Anstee, et al.
JHEP Reports : Innovation in Hepatology|October 9, 2024
Loss of biochemical response at any time worsens outcomes in UDCA-treated patients with primary biliary cholangitisSurain B Roberts, Woo Jin Choi, Lawrence Worobetz, et al.
Pageof 7